Option chain shows key data for Eastman Chemical's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Eastman Chemical.

Eastman Chemical (NYSE:EMN) Stock, Option Chain

Eastman Chemical

Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.

News

Downgrades

Markets

Analyst Ratings

Trading Ideas

ENPH

This Yum! Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

jim cramer chart shutter

Long Ideas

Media

LRCX

VLTO

Cramer is not sure how much higher Veralto can go unless it makes an acquisition or accelerates earnings, and he doesn&#39;t see that happening.

Jim Cramer: Veralto Is A &#39;Well-Run&#39; Company, Likes This Utilities Stock

Earnings

Earnings Beats

Large Cap

Mid Cap

Dividends

Eastman Chemical Company (NYSE: EMN) is benefiting from cost-cutting and productivity actions as well as its innovation-driven growth model amid challenges from soft demand in certain markets.

Shares of EMN are up 22.1% over the past year compared with a 7.4% decline of its industry.

Here&#39;s Why You Should Hold Onto Eastman Chemical Stock for Now

Eastman Chemical Co

Euro Manganese Inc

E-MONEE.COM INC by E-Monee.com, Inc.

Elementis PLC

PIMCO Enhanced Short Maturity Active ESG Exchange-Traded Fund

The company projects that it will generate:
<ul>
<li>greater than $2.1 billion of EBITDA and approximately $1.6 billion of cash from operations in a normalized macroeconomic environment before the benefit of circular investments, and</li>
<li>additional EBITDA of &gt;$500 million by 2029 through its circular initiatives:
<ul>
<li>&gt;$350 million of EBITDA from Kingsport, Tenn., and Longview, Texas, methanolysis projects, and</li>
<li>$150 million–$200 million of EBITDA from its cellulosic biopolymer platform</li>
</ul>
</li>
</ul>
The company also said it expects to generate an incremental $75 million–$100 million of EBITDA contribution in 2025 compared to 2024 from the Kingsport methanolysis facility.
Capital expenditures in 2025 are expected to be approximately $800 million. In 2026 and 2027, capital expenditures are expected to range between $800 million and $1 billion.

Guidance

Reported Earlier, Eastman Chemical Expects To Generate Significant EBITDA Growth Through Its Circular Economy Initiatives; Plans To Invest In Organic Growth For The Next Several Years

Christopher M. Killian, SVP &amp; CTO at Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>), executed a substantial insider sell on November 7, according to an SEC filing.
What Happened: Killian's decision to sell 3,061 shares of Eastman Chemical was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000915389/000091538924000229//Archives/edgar/data/915389/000091538924000229/0000915389-24-000229-index.htm">U.S. Securities and Exchange Commission</a> on Thursday. The total value of the sale is $321,405.
During Friday's morning session, Eastman Chemical shares up by 0.7%, currently priced at $104.26.
<h3>Get to Know Eastman Chemical Better</h3>
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
<h3>Financial Milestones: Eastman Chemical's Journey</h3>
Revenue Growth: Eastman Chemical displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 8.69%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Insights into Profitability:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 24.55%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Eastman Chemical's EPS is below the industry average. The company faced challenges with a current EPS of 1.55. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: Eastman Chemical's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.89, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: Eastman Chemical's P/E ratio of 13.88 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 1.31 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry benchmarks at 8.57, Eastman Chemical presents an attractive value opportunity.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Impact of Insider Transactions on Investments</h3>
Insider transactions serve as a piece of the puzzle in investment decisions, rather than the entire picture.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Cracking Transaction Codes</h3>
Examining transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000915389">Check Out The Full List Of Eastman Chemical's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

SVP & CTO At Eastman Chemical Sells $321K Of Stock

RBC Capital analyst Arun Viswanathan maintains Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Sector Perform and lowers the price target from $107 to $105.

Price Target

RBC Capital Maintains Sector Perform on Eastman Chemical, Lowers Price Target to $105

Deutsche Bank analyst David Begleiter maintains Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Hold and lowers the price target from $115 to $110.

Deutsche Bank Maintains Hold on Eastman Chemical, Lowers Price Target to $110

Wells Fargo analyst Michael Sison maintains Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Equal-Weight and lowers the price target from $118 to $110.

Wells Fargo Maintains Equal-Weight on Eastman Chemical, Lowers Price Target to $110

In the latest quarter, 4 analysts provided ratings for Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>), showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Eastman Chemical, presenting an average target of $114.25, a high estimate of $119.00, and a low estimate of $107.00. This upward trend is apparent, with the current average reflecting a 7.28% increase from the previous average price target of $106.50.
<img src="https://www.benzinga.com/files/images/story/2024/1730494833_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive Eastman Chemical is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$113.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$119.00</td>
<td>$114.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$118.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$107.00</td>
<td>$100.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Eastman Chemical. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Eastman Chemical compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Eastman Chemical's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Eastman Chemical's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EMN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Eastman Chemical analyst ratings.</a>
<h2>About Eastman Chemical</h2>
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
<h3>Eastman Chemical's Economic Impact: An Analysis</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, Eastman Chemical showcased positive performance, achieving a revenue growth rate of 1.68% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Eastman Chemical's net margin is impressive, surpassing industry averages. With a net margin of 9.73%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.12%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Eastman Chemical's ROA excels beyond industry benchmarks, reaching 1.55%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.89.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Eastman Chemical Stands With Analysts

WIIM

Eastman Chemical shares are trading lower. The company reported Q3 financial results.

Mizuho analyst John Roberts maintains Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Neutral and raises the price target from $107 to $113.

Mizuho Maintains Neutral on Eastman Chemical, Raises Price Target to $113

Eastman Chemical Sees FY24 EPS $7.50-$7.70 Vs $7.69

Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) reported quarterly earnings of $2.26 per share which beat the analyst consensus estimate of $2.14 by 5.61 percent. The company reported quarterly sales of $2.46 billion which beat the analyst consensus estimate of $2.38 billion by 3.63 percent. This is a 8.69 percent increase over sales of $2.27 billion the same period last year.

Eastman Chemical Q3 2024 Adj EPS $2.26 Beats $2.14 Estimate, Sales $2.46B Beat $2.38B Estimate

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Stephens &amp; Co. analyst Tommy Moll downgraded the rating for Emerson Electric Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) from Overweight to Equal-Weight and lowered the price target from $135 to $120. Emerson Electric shares closed at $109.25 on Tuesday. <a href="https://www.benzinga.com/quote/EMR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58c2a8e3b85e930001ba538f/biju-perincheril">Susquehanna analyst Biju Perincheril </a>downgraded Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) from Positive to Neutral and slashed the price target from $147 to $104. Enphase Energy shares closed at $92.04 on Tuesday. <a href="https://www.benzinga.com/quote/ENPH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Steven Cahall downgraded the rating for Omnicom Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMC#NYSE">OMC</a>) from Overweight to Equal-Weight while raised the price target from $106 to $110. Omnicom Group shares closed at $104.02 on Tuesday. <a href="https://www.benzinga.com/quote/OMC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen analyst Andrew Charles downgraded Yum! Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) from Buy to Hold and announced a price target of $145. Yum Brands shares closed at $133.22 on Tuesday. <a href="https://www.benzinga.com/quote/YUM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities analyst Steve Byrne downgraded the rating for Eastman Chemical Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) from Buy to Neutral but raised the price target from $114 to $119. Eastman Chemical shares closed at $110.32 on Tuesday. <a href="https://www.benzinga.com/quote/EMN/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying YUM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="460" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/16145951/image-132-1024x460.png" alt="" class="wp-image-599124" style="width:672px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/16145951/image-132-1024x460.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/16145951/image-132-300x135.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/16145951/image-132-768x345.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/16145951/image-132.png 1462w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow"><a href="https://www.benzinga.com/news/24/10/41358280/united-airlines-posts-upbeat-earnings-joins-morgan-stanley-u-s-bancorp-and-other-big-stocks-moving-h">United Airlines Posts Upbeat Earnings, Joins Morgan Stanley, U.S. Bancorp And Other Big Stocks Moving Higher On Wednesday</a>
</blockquote>

B of A Securities analyst Steve Byrne downgrades Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) from Buy to Neutral and raises the price target from $114 to $119.

B of A Securities Downgrades Eastman Chemical to Neutral, Raises Price Target to $119

Wells Fargo analyst Michael Sison maintains Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Equal-Weight and raises the price target from $105 to $118.

Wells Fargo Maintains Equal-Weight on Eastman Chemical, Raises Price Target to $118

In the latest quarter, 6 analysts provided ratings for Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>), showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $106.33, along with a high estimate of $111.00 and a low estimate of $100.00. Witnessing a positive shift, the current average has risen by 4.58% from the previous average price target of $101.67.
<img src="https://www.benzinga.com/files/images/story/2024/1728680490_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Eastman Chemical. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$107.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$105.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$108.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$111.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$107.00</td>
<td>$102.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Eastman Chemical. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Eastman Chemical compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Eastman Chemical's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Eastman Chemical's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EMN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Eastman Chemical analyst ratings.</a>
<h2>All You Need to Know About Eastman Chemical</h2>
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
<h3>Key Indicators: Eastman Chemical's Financial Health</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Positive Revenue Trend: Examining Eastman Chemical's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.68% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 9.73%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.12%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Eastman Chemical's ROA excels beyond industry benchmarks, reaching 1.55%. This signifies efficient management of assets and strong financial health.
Debt Management: Eastman Chemical's debt-to-equity ratio is below the industry average at 0.89, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Eastman Chemical Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)

RBC Capital analyst Arun Viswanathan maintains Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Sector Perform and raises the price target from $100 to $107.

RBC Capital Maintains Sector Perform on Eastman Chemical, Raises Price Target to $107

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said he likes GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>). &#8220;We're all looking for situations where we can play the environment and corporations, and <a href="https://www.benzinga.com/quote/GEV/analyst-ratings">we've got it,&#8221; he added.</a>
On Sept. 4, Jefferies initiated coverage on the stock with a Buy rating and announced a price target of $261.
Veralto Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLTO#NYSE">VLTO</a>) is a &#8220;very well-run&#8221; company, Cramer said. &#8220;I'm not sure how much more we can go higher unless it makes an acquisition or really accelerates earning, and I don't see that happening.&#8221;
On Aug. 13, UBS analyst Damian Karas initiated coverage on Veralto with a Neutral rating and announced a price target of $118.
When asked about Eastman Chemical Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>), he said, &#8220;I think the stock, with a 3% yield, is one of the better, one of the better plastic stocks in the market.&#8221;
On Aug. 20, Eastman named Iké Adeyemi as Chief Legal Officer.
Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) has &#8220;gone down too much,&#8221; he said. &#8220;I'd rather be a buyer, but buy it slowly, do not buy it once, that will only lead to pain.&#8221;
On Aug. 29, Lam Research raised its quarterly dividend from $2.00 to $2.30 per share.
Price Action:
<ul>
<li>GE Vernova shares fell 0.1% to settle at $198.33 on Friday.</li>
<li>Veralto shares declined 1% to close at $108.72 during Friday's session.</li>
<li>Lam Research shares fell 2.9% to close at $733.83 during Friday's session.</li>
<li>Eastman Chemical fell 0.9% to settle at $97.17 during the session.</li>
</ul>
Read Next:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40748893/over-40m-bet-on-pbf-energy-check-out-these-4-stocks-executives-are-buying"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40748893/over-40m-bet-on-pbf-energy-check-out-these-4-stocks-executives-are-buying">Over $40M Bet On PBF Energy? Check Out These 4 Stocks Executives Are Buying</a></li>
</ul>
Image: Shutterstock

Jim Cramer: Veralto Is A 'Well-Run' Company, Likes This Utilities Stock

Eastman Chemical Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/emn#NYSE">EMN</a>) is benefiting from cost-cutting and productivity actions as well as its innovation-driven growth model amid challenges from soft demand in certain markets.
Shares of EMN are up 22.1% over the past year compared with a 7.4% decline of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/40/76792.jpg?v=1565582696" />
Image Source: Zacks Investment Research
Let&#39;s find out why this Zacks Rank #3 (Hold) stock is worth retaining at the moment.
<h2>Eastman Chemical Gains on Cost Actions &amp; Innovation</h2>
Eastman is gaining from its actions to manage costs. It is expected to benefit from lower operating costs from its operational transformation program in 2024.
EMN is taking action to keep its manufacturing and administrative costs in control. It achieved cost savings of around $200 million in 2023, net of inflation.&nbsp; Pricing initiatives and lower raw material and energy costs are also expected to support the company&#39;s bottom line. The company plans to maintain pricing discipline and improve asset utilization throughout the year.
Eastman aims to increase new business revenues by utilizing its innovation-driven growth strategy. Innovation and market development initiatives are expected to support its sales volumes. Its specialty portfolio is expected to drive sales growth across key end markets such as consumer durables, building &amp; construction and transportation.
The company is also expected to gain from the revenues and earnings generated by its Kingsport methanolysis facility in 2024. It anticipates a $50 million incremental EBITDA contribution from the Kingsport facility.
Eastman Chemical also remains focused on maintaining a disciplined approach to capital allocation with an emphasis on debt reduction. It returned $526 million to shareholders in 2023 through dividends and share repurchases. It also raised its dividend for the 14th consecutive year. EMN expects to repurchase shares worth around $300 million in 2024.
<h2>Demand Weakness a Concern for EMN Stock</h2>
EMN is exposed to headwinds from weak demand in certain markets. It is seeing soft demand in building &amp; construction and cautious customer behavior in consumer durables and electronics. Demand in building &amp; construction remains sluggish in most regions.
While Eastman Chemical is seeing an end of customer inventory de-stocking across most of its end markets, the same is expected to continue in medical applications in the second half of 2024. Weaker demand is expected to adversely impact its performance in the third quarter of 2024.
<div class="chart_embed">
<h3>Eastman Chemical Company Price and Consensus</h3>
<img alt="Eastman Chemical Company Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/3c/1725614461.png" style="height:265px; width:583px" title="" />
Eastman Chemical Company price-consensus-chart | Eastman Chemical Company Quote
</div>
<h2>Stocks to Consider</h2>
Better-ranked stocks in the Basic Materials space are Newmont Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nem#NYSE">NEM</a>), Element Solutions Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/esi#NYSE">ESI</a>) and Eldorado Gold Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ego#NYSE">EGO</a>), each sporting a Zacks Rank #1 (Strong Buy).
The Zacks Consensus Estimate for Newmont&#39;s current-year earnings is pegged at $2.82, indicating a rise of 75.2% from year-ago levels. The Zacks Consensus Estimate for NEM&#39;s earnings has increased 16% in the past 60 days. The stock has rallied around 35% in the past year.
The consensus estimate for Element Solutions&#39; current-year earnings has increased by 0.7% in the past 60 days. ESI beat the consensus estimate in three of the last four quarters while delivering in-line results on the other occasion. In this timeframe, it delivered an earnings surprise of around 3.8%, on average.
The Zacks Consensus Estimate for Eldorado Gold&#39;s current year earnings is pegged at $1.35 per share, indicating a year-over-year rise of 136.8%. EGO beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 430.3%. The company&#39;s shares have rallied roughly 73% in the past year.
<a href="https://www.zacks.com/stock/news/2332583/here-s-why-you-should-hold-onto-eastman-chemical-stock-for-now?cid=CS-BENZ-FT-analyst_blog|rank_focused-2332583">To read this article on Zacks.com click here.</a>

Here's Why You Should Hold Onto Eastman Chemical Stock for Now

Piper Sandler analyst Charles Neivert maintains Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Neutral and maintains $105 price target.

Piper Sandler Maintains Neutral on Eastman Chemical, Maintains $105 Price Target

RBC Capital analyst Arun Viswanathan reiterates Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Sector Perform and maintains $100 price target.

Reiteration

RBC Capital Reiterates Sector Perform on Eastman Chemical, Maintains $100 Price Target

Deutsche Bank analyst David Begleiter maintains Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Hold and raises the price target from $100 to $108.

Deutsche Bank Maintains Hold on Eastman Chemical, Raises Price Target to $108

Barclays analyst Michael Leithead maintained a Hold rating on Eastman Chemical (EMN – Research Report) today and set a price target of $111.00. The...

Barclays Sticks to Their Hold Rating for Eastman Chemical (EMN)

Wells Fargo lowered the firm's price target on Eastman Chemical (EMN) to $110 from $118 and keeps an Equal Weight rating on the shares despite doub...

Eastman Chemical price target lowered to $110 from $118 at Wells Fargo

BofA analyst Salvator Tiano lowered the firm's price target on Eastman Chemical (EMN) to $115 from $119 and keeps a Neutral rating on the shares. T...

Eastman Chemical price target lowered to $115 from $119 at BofA

RBC Capital lowered the firm's price target on Eastman Chemical (EMN) to $105 from $107 and keeps a Sector Perform rating on the shares after its Q...

Eastman Chemical price target lowered to $105 from $107 at RBC Capital

Short sellers boost bets against materials stocks amid demand uncertainty

Analyst Vincent Andrews of Morgan Stanley maintained a Buy rating on Eastman Chemical (EMN – Research Report), retaining the price target of $125.0...

Eastman Chemical: Buy Rating Highlighting Growth Potential Through Recycling Initiatives

Dividend Income: Lanny's October 2024 Summary

Morgan Stanley sees little in Eastman's current share price for the potential upside from its molecular/chemical recycling franchise, which makes t...

Morgan Stanley sees positive response to increased disclosure at Eastman event

Quality cyclicals are expected to continue going up, here are the top-rated by Morgan Stanley

Eastman Chemical ( ($EMN) ) has shared an announcement. Eastman Chemical Company, at its 2024 Circular Economy Deep Dive event, highlighted its str...

Eastman Chemical Aims for Growth via Circular Economy

AAPL

ADSK

ALLY

AVTR

BURL

DASH

EWBC

FANG

GOOGL

HBAN

HUBS

IDXX

INVZ

NFLX

NTNX

NVDA

ROST

SBAC

SBUX

SPOT

TEAM

XRAY

Press Releases

Eastman Announces Pricing of $500 Million 5.000% Notes due 2029

Eastman Board Declares Dividend

Eastman Chemical Company Announces Early Tender Results for 3.800% Notes Due 2025

Eastman Chemical Company Announces Pricing of Tender Offer for 3.800% Notes Due 2025

Eastman Names Iké Adeyemi as Chief Legal Officer

Eastman CFO Willie McLain to address the Morgan Stanley 12th Annual Laguna Conference

Eastman Schedules Third-Quarter 2024 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast, and Release of Additional Information

Comments

Eastman Chemical

Eastman Chemical (EMN) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga